Pages that link to "Q34442331"
Jump to navigation
Jump to search
The following pages link to Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis (Q34442331):
Displaying 12 items.
- Adenovirus-mediated gene transfer of mutated IkappaB kinase and IkappaBalpha reveal NF-kappaB-dependent as well as NF-kappaB-independent pathways of HAS1 activation (Q34463886) (← links)
- Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy (Q34585191) (← links)
- Upcoming biologic agents for the treatment of rheumatic diseases (Q35111832) (← links)
- Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles (Q36395067) (← links)
- Metalloproteases as potential therapeutic targets in arthritis treatment (Q37030862) (← links)
- The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer (Q37620350) (← links)
- TNF-α signalling and inflammation: interactions between old acquaintances (Q38107792) (← links)
- Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease (Q38185979) (← links)
- Overexpression of ADAMTS-7 leads to accelerated initiation and progression of collagen-induced arthritis in mice (Q40169907) (← links)
- Polyamine depletion inhibits NF-kappaB binding to DNA and interleukin-8 production in human chondrocytes stimulated by tumor necrosis factor-alpha. (Q40435824) (← links)
- p38MAP kinase inhibitors. Part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold (Q44249286) (← links)
- [Intracellular signaling transduction pathways. Potential targets in the treatment of rheumatic diseases] (Q84756240) (← links)